Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...

Carrier-Mediated Transport

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...

ABC Transporters: Exporter

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...

Cellular Membranes and Drug Transport

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.

Drug Elimination by Renal Route: Tubular Secretion

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...

Nonlinear Pharmacokinetics: Role of Transporters

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Interaction of the P-Glycoprotein Multidrug Transporter with Sterols.

Biochemistry·2015

Same author

Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.

ACS chemical neuroscience·2014

Same author

Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication.

Bioorganic & medicinal chemistry·2014

Same author

A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.

Cancer letters·2013

Same author

Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates.

Biochemistry·2012

Same author

Determining P-glycoprotein-drug interactions: evaluation of reconstituted P-glycoprotein in a liposomal system and LLC-MDR1 polarized cell monolayers.

Journal of pharmacological and toxicological methods·2012

Search research articles

Related Experiment Video

Updated: May 28, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

The P-glycoprotein multidrug transporter.

Frances J Sharom¹

¹Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada, N1G 2W1. fsharom@uoguelph.ca

Essays in Biochemistry

|October 5, 2011

Summary

This summary is machine-generated.

P-glycoprotein (Pgp) is an efflux pump that transports drugs and other compounds across cell membranes. Understanding its transport mechanism is key to improving drug delivery and cancer chemotherapy.

More Related Videos

Isolation of Cerebral Capillaries from Fresh Human Brain Tissue

Isolation of Cerebral Capillaries from Fresh Human Brain Tissue

Published on: September 12, 2018

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Published on: June 13, 2021

Related Experiment Videos

Last Updated: May 28, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

Isolation of Cerebral Capillaries from Fresh Human Brain Tissue

Isolation of Cerebral Capillaries from Fresh Human Brain Tissue

Published on: September 12, 2018

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Published on: June 13, 2021

Area of Science:

Biochemistry
Molecular Biology
Pharmacology

Background:

P-glycoprotein (Pgp) is an ATP-powered efflux pump involved in xenobiotic transport.
Pgp plays a critical role in drug distribution, particularly at the blood-brain barrier and intestine.
Pgp overexpression in cancers contributes to multidrug resistance, impacting chemotherapy efficacy.

Purpose of the Study:

To elucidate the molecular mechanisms of P-glycoprotein (Pgp) mediated drug transport.
To understand the structural basis for Pgp's broad substrate specificity.
To identify potential therapeutic strategies targeting Pgp for improved drug delivery and cancer treatment.

Main Methods:

X-ray crystallography to determine the structure of Pgp.
Biochemical assays to study ATP hydrolysis and substrate binding.
Analysis of Pgp's role in drug transport across biological barriers.

Main Results:

Pgp possesses a large, flexible binding pocket accommodating multiple drug substrates.
Substrates are transported from the membrane into the aqueous phase, potentially via a 'flippase' mechanism.
ATP hydrolysis by nucleotide-binding domains appears to drive transport, though the precise mechanism is under investigation.

Conclusions:

Pgp's structure facilitates the transport of diverse hydrophobic compounds.
Modulators of Pgp activity hold promise for enhancing drug efficacy and overcoming cancer resistance.
Further research is needed to fully understand the Pgp transport cycle and its coupling to ATP hydrolysis.